{
    "topic": "healthcare",
    "source": "BBC News",
    "bias": 1,
    "url": "http://www.bbc.com/news/world-us-canada-28663443",
    "title": "Ebola outbreak risk to US 'very low'",
    "date": "",
    "authors": "",
    "content": "US National Security Adviser Susan Rice has said the risk of Ebola transmission in the US is `` very low '' , as a second ailing American arrives for treatment .\nOne US aid worker is being cared for in Atlanta while his colleague , also infected , is on her way from Liberia to the same specialist hospital .\nAnother man , in New York , is being tested after travelling to the region .\nSince February , 887 people have died in four West African countries . The World Bank has given $ 200m ( \u00a3120m ) to help .\nThe Centers for Disease Control ( CDC ) in the US has received at least 100 calls from people questioning why the sick aid workers should be allowed into the country .\nBut Ms Rice told NBC the risk to Americans was deemed `` very low '' by the CDC .\n`` We have in this country the protocols to isolate and manage any patient who may present with those symptoms of the disease . ''\nNancy Writebol , 59 , an aid worker infected with the virus in Liberia , is expected to arrive in Atlanta for treatment on Tuesday morning .\nShe is said to be progressing after receiving two doses of a experimental treatment not previously tested on humans .\nHer husband , David Writebol , has told the president of the aid agency she was working for that she is weak but showing signs of improvement .\nA week ago the family was considering funeral arrangements , but now they were relieved and cautiously optimistic about her condition , he said .\nHer colleague , Dr Kent Brantly , 33 , who also received the experimental treatment , arrived at Emory University Hospital on Saturday and was able to walk into hospital , where he is being held in isolation .\nKnown as ZMapp , the treatment boosts the immune system 's ability to fight off Ebola through antibodies made by lab animals exposed to elements of the virus .\nA couple of experimental treatments have been used on a compassionate basis .\nThe approach is based on the idea that antibodies against the Ebola virus might help the body fight off the infection .\nAn antibody is a protein produced by the immune system in response to harmful invaders , such as viruses .\nIt had shown promise in monkeys , CNN reports , but had never before been tested on humans .\nIt is unclear if the Americans ' improvements are related to the drug . Dr Brantly was reportedly also given a blood transfusion from a boy who recovered from Ebola while in his care .\nIn a statement , the company said very little of the drug is available and they were `` co-operating with appropriate government agencies to increase production as quickly as possible '' .\nThe US Food and Drug Administration ( FDA ) must grant permission to use such treatments on humans in the US , but the agency does not have authority over its use outside the country .\nAn FDA spokeswoman could not confirm or deny FDA granting access to any experimental therapy for the aid workers inside the US , the Associated Press reports .\nThe two aid workers were serving with aid groups helping fight the Ebola outbreak in Liberia .\nThere is no cure or vaccine for Ebola , but patients have a better chance of survival if they receive early treatment .\nThe current outbreak is killing between 50 % and 60 % of people infected . Initial flu-like symptoms can lead to external haemorrhaging from areas like eyes and gums , and internal bleeding which can lead to organ failure .",
    "content_original": "Media playback is unsupported on your device Media caption Nancy Writebol arrived at Atlanta's Emory Hospital on Tuesday\n\nUS National Security Adviser Susan Rice has said the risk of Ebola transmission in the US is \"very low\", as a second ailing American arrives for treatment.\n\nOne US aid worker is being cared for in Atlanta while his colleague, also infected, is on her way from Liberia to the same specialist hospital.\n\nAnother man, in New York, is being tested after travelling to the region.\n\nSince February, 887 people have died in four West African countries. The World Bank has given $200m (\u00a3120m) to help.\n\nUntested in humans\n\nThe Centers for Disease Control (CDC) in the US has received at least 100 calls from people questioning why the sick aid workers should be allowed into the country.\n\nBut Ms Rice told NBC the risk to Americans was deemed \"very low\" by the CDC.\n\n\"We have in this country the protocols to isolate and manage any patient who may present with those symptoms of the disease.\"\n\nNancy Writebol, 59, an aid worker infected with the virus in Liberia, is expected to arrive in Atlanta for treatment on Tuesday morning.\n\nShe is said to be progressing after receiving two doses of a experimental treatment not previously tested on humans.\n\nHer husband, David Writebol, has told the president of the aid agency she was working for that she is weak but showing signs of improvement.\n\nA week ago the family was considering funeral arrangements, but now they were relieved and cautiously optimistic about her condition, he said.\n\nImage copyright AP Image caption Nancy Writebol is on her way to a special isolation ward at Atlanta's Emory University Hospital\n\nHer colleague, Dr Kent Brantly, 33, who also received the experimental treatment, arrived at Emory University Hospital on Saturday and was able to walk into hospital, where he is being held in isolation.\n\nKnown as ZMapp, the treatment boosts the immune system's ability to fight off Ebola through antibodies made by lab animals exposed to elements of the virus.\n\nAnalysis - Helen Briggs, health editor, BBC News website\n\nA couple of experimental treatments have been used on a compassionate basis.\n\nThe approach is based on the idea that antibodies against the Ebola virus might help the body fight off the infection.\n\nAn antibody is a protein produced by the immune system in response to harmful invaders, such as viruses.\n\nNew treatments for Ebola\n\nImage copyright AP Image caption Health officials from Mount Sinai Hospital in New York said it was unlikely a patient being tested had ebola\n\nIt had shown promise in monkeys, CNN reports, but had never before been tested on humans.\n\nFlu-like symptoms\n\nIt is unclear if the Americans' improvements are related to the drug. Dr Brantly was reportedly also given a blood transfusion from a boy who recovered from Ebola while in his care.\n\nIn a statement, the company said very little of the drug is available and they were \"co-operating with appropriate government agencies to increase production as quickly as possible\".\n\nMedia playback is unsupported on your device Media caption Dr Anthony Fauci on hopes for an Ebola vaccine\n\nThe US Food and Drug Administration (FDA) must grant permission to use such treatments on humans in the US, but the agency does not have authority over its use outside the country.\n\nAn FDA spokeswoman could not confirm or deny FDA granting access to any experimental therapy for the aid workers inside the US, the Associated Press reports.\n\nThe two aid workers were serving with aid groups helping fight the Ebola outbreak in Liberia.\n\nThere is no cure or vaccine for Ebola, but patients have a better chance of survival if they receive early treatment.\n\nThe current outbreak is killing between 50% and 60% of people infected. Initial flu-like symptoms can lead to external haemorrhaging from areas like eyes and gums, and internal bleeding which can lead to organ failure.",
    "source_url": "www.bbc.com",
    "bias_text": "center",
    "ID": "ejbWdH8sNJzeNVNa"
}